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fAbstract
The reaction of [CpRu(PPh3)2Cl] and [CpOs(PPh3)2Br] with chelating 2-(2
0-pyridyl)imidazole (N \ N) ligands and NH4PF6 yield
cationic complexes of the type [CpM(N \ N)(PPh3)]+ (1: M = Ru, N \ N = 2-(2 0-pyridyl)imidazole; 2: M = Ru, N \ N = 2-(2 0-py
idyl)benzimidazole; 3: M = Ru, N \ N = 2-(2 0-pyridyl)-4,5-dimethylimidazole; 4: M = Ru, N \ N = 2-(2 0-pyridyl)-4,5-diphenylimidaz
ole; 5: M = Os, N \ N = 2-(2 0-pyridyl)imidazole; 6: M = Os, N \ N = 2-(2 0-pyridyl)benzimidazole). They have been isolated an
characterized as their hexaﬂuorophosphate salts. Similarly, in the presence of NH4PF6, [Cp*Ir(l-Cl)Cl]2 reacts in dry methanol wit
N \ N chelating ligands to aﬀord in excellent yield [Cp*Ir(N \ N)Cl]PF6 (7: N \ N = 2-(2 0-pyridyl)imidazole; 8: N \ N = 2-(2 0-py
idyl)benzimidazole). All the compounds have been characterized by infrared and NMR spectroscopy and the molecular structure o
[1]PF6, [2]PF6 and [7]PF6 by single-crystal X-ray structure analysis.
Keywords: Cyclopentadienyl; Pentamethylcyclopentadienyl; Ruthenium; Osmium; Iridium; 2-(2 0-Pyridyl)imidazole-
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s1. Introduction
The chemistry of cyclopentadienyl bisphosphine ruthe
nium complexes [CpRu(PPh3)2X] is the family of an are
of active research [1] due to their high reactivity and cata
lytic activities [2,3]. These properties have prompted wide
spread interest regarding both the synthetic application
and the mechanistic features of cyclopentadienyl complexe
for a large number of transition metals. Similarly, there
an increasing interest in the organometallic chemistry o
osmium as the nature of the diﬀerences from its lighter con
gener ruthenium becomes more apparent [4]. However, ths
-
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E-mail addresses: mohanrao59@hotmail.com, mohanraokollipara@
yahoo.co.in (M.R. Kollipara).complex [CpOs(PPh3)2Br] chemistry have not been studie
extensively due to lower kinetic liability of the tripheny
phosphines compared to its ruthenium analogue [5]. Unt
recently far fewer studies had been carried out on penta
methylcyclopentadienyl rhodium(III) and iridium(III
complexes with chelating N \ N-donor bases [6]. Th
chemistry of [CpRu(PPh3)2Cl] is characterized by facile dis
placement of either chloride or one or both triphenylphos
phine ligands, aﬀording cationic or neutral compound
respectively, depending on the solvent and reaction cond
tions [7]. The electron rich metal center contributes to th
stabilization of unusual ligands such as vinyllidine
and allenylidines [8]. We had reported that the reaction
of cyclopentadienyl ruthenium(II), [Cp*Ru(PPh3)2
(CH3CN)]
+ and [(g5-C9H7)Ru(PPh3)2(CH3CN)]
+ [9] wit
a variety of nitrogen based ligands.
2In this paper, as a part of our continuing study, we
would like to report the synthesis and characterization of
new cationic cyclopentadienyl (Cp) ruthenium(II),
osmium(II) and pentamethylcyclopentadienyl (Cp*) irid-
ium(III) complexes with chelating N \ N-donor ligands
[L1 = 2-(2
0-pyridyl)imidazole, L2 = 2-(2 0-pyridyl)benzimid-
azole, L3 = 2-(2
0-pyridyl)-4,5-dimethylimidazole, L4 = 2-
(2 0-pyridyl)-4,5-diphenylimidazole (Scheme 1). In order to
conﬁrm the nature of bonding, the molecular structures
of [CpRu{2-(2 0-pyridyl)imidazole}(PPh3)]PF6 ([1]PF6),
[CpRu{2-(2 0-pyridyl)benzimidazole}(PPh3)]PF6 ([2]PF6)
and [Cp*Ir{2-(2
0-pyridyl)imidazole}Cl] PF6 ([7]PF6) have
been solved by X-ray crystallography.2. Experimental
Elemental analyses were performed on a Perkin–Elmer-
2400 CHN/O analyzer. Infrared spectra were recorded on a
Perkin–Elmer Model 983 spectrophotometer with the sam-
ple prepared as KBr pellets. The 1H NMR spectra were
recorded on a Bruker ACF-300 (300 MHz) spectrometer
in CDCl3 solvents with TMS as internal reference. All
chemicals used were of reagent grade. All reactions were
carried out in distilled and dried solvents. Ruthenium tri-
chloride, iridium trichloride and osmium tetraoxide were
purchased from Arora Matthey Ltd. and Aldrich. The 2-
(2 0-pyridyl)imidazole and its derivatives were prepared by
following a literature procedure [10]. 2-(2 0-Pyridyl)benz-
imidazole (Aldrich), pyridine-2-aldehyde (Fluka), glyoxal
(Aldrich), 2,3-butanedione (Aldrich) and benzyl (Sd Fine)
were used as received. The precursor’s complexes
[CpRu(PPh3)2Cl], [CpOs(PPh3)2Br] [11] and [Cp*Ir(l-
Cl)Cl]2 [12] were prepared by following the reported litera-
ture methods.
2.1. Synthesis of [CpRu(N \ N)(PPh3)]PF6
The following general procedure was used for the prep-
aration of complexes [1]PF6 to [4]PF6.
2.1.1. Preparation of [1]PF6
A mixture of [CpRu(PPh3)2Cl] (0.1 g, 0.14 mmols), 2-
(2 0-pyridyl)imidazole (0.04 g, 0.28 mmols) and NH4PF6
(0.046 g, 0.28 mmols) was reﬂuxed in dry methanol
(20 ml) under a nitrogen atmosphere for 6 h. The yellow
suspension turns to a light yellow color. The solvent isN
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Scheme 1. Ligands and numberinevaporated at reduced pressure. Then the residue is dis-
solved in dichloromethane (5 ml), and the solution ﬁltered
to remove ammonium chloride. The yellow solution is con-
centrated (2 ml) and by addition of an excess of hexane the
orange yellow product precipitates. The compound is
ﬁltered and dried under vacuum to give [1]PF6.
Complex [CpRu{2-(2 0-pyridyl)imidazole}(PPh3)]PF6
[1]PF6 (Yield: 63 mg, 64%). Elemental Anal. Calc. for
C31H27N3F6P2Ru: C, 51.81; H, 3.76; N, 5.85. Found: C,
51.54; H, 4.17; N, 5.44%. IR (KBr pellets, cm1): 1606
(mC@C), 1480, 1440 (mC@N), 857 (mPF6),
1H NMR (CDCl3,
d): 12.01 (s, 1H, NH); 9.04 (d, JH–H = 5.74 Hz, 1H, H6);
8. 75 (d, JH–H = 6.08 Hz, H7); 8.50 (d, JH–H = 6.02 Hz,
H8); 8.00 (d, JH–H = 5.12 Hz, 1H, H3); 7.78 (m, 15H, Ph);
7.70 (t, 1H, H4); 7.32 (t, 1H, H5); 4.68 (s, 5H, C5H5).
Complex [CpRu{2-(2 0-pyridyl)benzimidazole}(PPh3)]-
PF6 [2]PF6 (Yield: 65 mg, 62%). Elemental Anal. Calc.
for C35H29F6P2N3Ru: C, 54.69; H, 3.78; N, 5.47. Found:
C, 54.87; H, 4.12; N, 5.67%. IR (KBr pellets, cm1): 1613
(mC@C), 1447 (mC@N), 850 (mPF6),
1H NMR (CDCl3, d):
12.01 (s, 1H, NH); 8.94 (d, JHH = 5.42 Hz, 1H, H6); 8.07
(d, JHH = 5.80 Hz, 1H, H3); 7.98 (t, 1H, H4); 7.90 (t, 1H,
H5); 7.48 (m, 15H, Ph); 7.32 (m, 4H H7–10); 4.64 (s, 5H,
C5H5).
Complex [CpRu{2-(2 0-pyridyl)-4,5-dimethylimidazole}-
(PPh3)]PF6 [3]PF6 (Yield: 64 mg, 62%). Elemental Anal.
Calc. for C33H31F6P2N3Ru: C, 53.08; H, 4.16; N, 5.63.
Found: C, 53.28; H, 4.66; N, 5.77%. IR (KBr pellets,
cm1): 1604 (mC@C), 1480, 1447 (mC@N); 855 (mP–F),
1H
NMR (CDCl3, d): 12.10 (s, 1H, NH); 8.50 (d, JH–H =
5.74 Hz, 1H, H6); 8.18 (d, JH–H = 5.00 Hz, 1H, H3); 7.53
(m, 15H, Ph); 7.39 (t, 1H, H4); 7.28 (t, 1H, H5); 4.67 (s,
5H, C5H5); 3.21 (s, 6H, CH3).
Complex [CpRu{2-(2 0-pyridyl)-4,5-diphenylimidazole}-
(PPh3)]PF6 [4]PF6 (Yield: 70 mg, 60%). Elemental Anal.
Calc. for C43H35N3P2F6Ru: C, 59.31; H, 4.02; N, 4.83.
Found: C, 60.23; H, 4.23; N, 5.13%. IR (KBr pellets,
cm1): 1600 (mC@C), 1480, 1440 (mC@N), 850 (mP–F),
1H
NMR (CDCl3, d): 8.50 (d, JH–H = 5.0 Hz, 1H, H6); 8.27
(d, JH–H = 5.73 Hz, 1H, H3), 7.92 (m, 25H, Ph); 7.60 (t,
1H, H4); 7.37 (t, 1H, H5); 4.62 (s, 5H, C5H5).
2.2. Synthesis of [CpM(N \ N)(PPh3)]PF6
These complexes were prepared by the same method
given in Section 2.1 using of [CpOs(PPh3)2(CH3CN)]PF6
instead of [CpRu(PPh3)2Cl].N
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3Complex [CpOs{2-(2 0-pyridyl)imidazole}(PPh3)]PF
[5]PF6 (Yield: 48 mg, 57%). Elemental Anal. Calc. fo
C31H27N3P2F6Os: C, 46.09; H, 3.35; N, 5.21. Found: C
46.36; H, 4.03; N, 5.65%. IR (KBr pellets, cm1): 160
(mC@C), 1480, 1440 (s, mC@N), 885 (s, br, mPF6)
1H NMR
(CDCl3, d): 8.95 (d, JH–H = 5.7 Hz, 1H, H6); 8.78 (d
JH–H = 6.05 Hz, 1H, H3); 8.63 (d, JH–H = 6.12 Hz, 1H
H7); 8.59 (d, JH–H = 5.52 Hz, 1H, H8); 7.89 (m, 15H, Ph
7.75 (t, 1H, H4); 7.48 (t, 1H, H5); 4.59 (s, 5H, C5H5).
Complex [CpOs{2-(2 0-pyridyl)benzimidazole}(PPh3)
PF6 [6]PF6 (Yield: 46 mg, 52%). Elemental Anal. Calc
for C35H29N3P2F6Os: C, 49.01; H, 3.38; N, 4.90. Found
C, 49.15; H, 3.56; N, 5.15%. IR (KBr pellets, cm1): 161
(mC@C), 1447 (mC@N), 885 (s, br, mPF6).
1H (NMR, CDCl
d): 8.50 (d, JH–H = 5.2 Hz, 1H, H6); 8.10 (d, JH–H =
5.2 Hz, 1H, H3); 7.93 (m, 15H, Ph); 7.78 (t, 1H, H4); 7.5
(t, 1H, H5); 7.37 (m, 4H H7–10); 4.65 (s, 5H, C5H5).
2.3. Synthesis of [Cp*Ir(N \ N)Cl]PF6
These complexes were prepared by the same metho
given in Section 2.1 using 0.5 equiv. of [Cp*Ir(l-Cl)Cl
instead of 1 equiv. of [CpM(PPh3)2Cl].
Complex [Cp*Ir{2-(2
0-pyridyl)imidazole}Cl]PF6 [7]PF
(Yield: 52 mg, 64%). Elemental Anal. Calc. fo
C18H22ClN3F6PIr: C, 33.13; H, 3.37; N, 6.44. Found: C
32.87; H, 3.88; N, 6.23%. IR (KBr pellets, cm1): 160
(mC@C), 1460–1327 (mC@N), 850 (mP–F),
1H NMR (CDCl
d): 8.94 (d, JH–H = 6.4 Hz, 1H, H6); 8.50 (d, JH–H =
6.12 Hz, 1H, H3); 8.00 (d, JH–H = 6.03 Hz, 1H, H7); 7.9
(d, JH–H = 5.23 Hz, 1H, H8); 7.73 (t, 1H, H4); 7.43 (
1H, H5); 1.86 (s, 15H, C5Me5).
Complex [Cp*Ir{2-(2
0-pyridyl)benzimidazole}Cl]PF
[8]PF6 (Yield: 54 mg, 62%). Elemental Anal. Calc. fo
C22H24ClN3F6PIr: C, 37.61; H, 3.42; N, 5.98. Found: C
37.52; H, 3.87; N, 6.15%. IR (KBr pellets, cm1): 160
(mC@C), 1474–1407 (mC@N), 850 (mP–F),
1H NMR (CDCl
d): 8.97 (d, JH–H = 5.63 Hz, 1H, H6); 8.90 (d, JH–H =
5.29 Hz, 1H, H3); 7.85 (t, 1H, H4); 7.43 (t, 1H, H5); 7.2
(m, 4H, H7–10); 1.82 (s, 15H, C5Me5).
2.4. Single-crystal X-ray structures analyses
Crystal suitable for X-ray diﬀraction study fo
compound [1]PF6, [2]PF6 and [7]PF6 were grown by slow
diﬀusion of diethylether into dichloromethane solution o
complexes [1]PF6, [2]PF6 and [7]PF6, respectively. Th
orange reddish crystals of compound [1]PF6 and [7]PF
were mounted on a Stoe Image Plate Diﬀraction system
equipped with a / circle goniometer, using Mo Ka graphit
monochromated radiation (k = 0.71073 A˚) with / rang
0–200, increment of 1.2, Dmax–Dmin = 12.45–0.81 A˚
Whereas crystal of [2]PF6 was mounted on a Bruker Ape
CCD diﬀractometer in a full reciprocal sphere equippe
with a CCD detector, X-ray intensity data were collecte
with Mo Ka graphite monochromated radiation a
120(2) K, with 0.3x scan mode and 10 second per frameThe intensity data were corrected for Lorenz and polariza
tion eﬀects. The structures were solved by direct method
using the program SHELXS-97 [13]. Reﬁnement and all fur
ther calculations were carried out using SHELXL-97 [14
The H-atoms were included in calculated positions an
treated as riding atoms using the SHELXL default parame
ters. The non-H-atoms were reﬁned anisotropically, usin
weighted full-matrix least-square on F2. In [2]PF6 Æ H2O
the –C5H4NC3N2H– fragment of the 2-(2
0-pyridyl)benz
imidazole was found to be disordered over two position
and the partial occupancy factor was reﬁned at 76:24
Crystallographic details are summarized in Table 1. Fig
1, 2 and 4 are drawn with ORTEP32 [15] while Figs. 3 an
5 are drawn with MERCURY [16].
3. Results and discussion
The reactions in dry methanol of [CpRu(PPh3)2Cl] an
[CpOs(PPh3)2Br] (Cp = g
5-C5H5) with an excess of chela
ing N \ N-ligands and NH4PF6 result, under reﬂuxing con
ditions, in the dissociation of one triphenylphosphine an
the halide ligands to yield the monocationic complexe
[CpM(N \ N)(PPh3)]+ (1: M = Ru, N \ N = 2-(2 0-pyridy
imidazole; 2: M = Ru, N \ N = 2-(2 0-pyridyl)benzimid
azole; 3: M = Ru, N \ N = 2-(2 0-pyridyl)-4,5-dimethylim
dazole; 4: M = Ru, N \ N = 2-(2 0-pyridyl)-4,5-dipheny
imidazole; 5: M = Os, N \ N = 2-(2 0-pyridyl)imidazole; 6
M= Os, N \ N = 2-(2 0-pyridyl)benzimidazole), se
Scheme 2. The compounds are isolated and characterize
as hexaﬂuorophosphate salts.
In the case of the reaction of the dinuclear iridium(III
complex [Cp*Ir(l-Cl)Cl]2 (Cp = g
5-C5Me5) with 2 equiv
of chelating N \ N-ligands in the presence of NH4PF
cleavage of the chloro-bridge followed by dissociation o
one chloride ligand, aﬀords the complexes [Cp*Ir{2-(2
pyridyl)imidazole}Cl]PF6([7]PF6) and [Cp*Ir{2-(2
0-pyr
idyl)benzimidazole}Cl]PF6 ([8]PF6), see Scheme 3.
The complexes 1–8 are pale yellow to orange reddis
colored. They are highly soluble in polar solvents such a
chloroform, acetone, methanol, dichloromethane etc., bu
insoluble in non-polar solvents such as hexane, pentan
etc., C, H, N analyses, IR, 1H NMR spectroscopic dat
were given in the experimental section, which supporte
the formation of these complexes. The X-ray structure
of representative complexes 1, 2 and 7 were determine
to conﬁrm the structure of the complexes (1–8). The infra
red spectra of complexes 1–6 exhibited very strong bands a
1613–1600 cm1 and 1480–1440 cm1corresponding t
phenyl groups of triphenylphosphine and N-bases, whil
in complexes 7 and 8 prominent peaks were observed a
1600 cm1 and 1474–1327 cm1. The counter ion (PF6
exhibit a strong band around 845 cm1 for mPF6 group.
The protons’ corresponding to the cyclopentadieny
ligands appear in the region of 4.6–4.7 ppm while the tr
phenylphosphine peaks are observed as a multiplet in th
aromatic region between 7 and 8 ppm. The chemical shift
of cyclopentadienyl groups appear downﬁeld as compare
Table 1
Crystallographic and structure reﬁnement parameters for complexes [1]PF6, [2]PF6 Æ H2O and [7]PF6
[1]PF6 [2]PF6 Æ H2O [7]PF6
Chemical formula C31H27F6N3P2Ru C35H31F6N3OP2Ru C18H22ClF6N3PIr
Formula weight 718.57 786.64 653.01
Crystal system monoclinic triclinic triclinic
Space group P21/c (no. 14) P1 (no. 2) P1 (no. 2)
Crystal colour and shape orange block red block red block
Crystal size 0.32 · 0.20 · 0.20 0.28 · 0.23 · 0.18 0.35 · 0.26 · 0.21
a (A˚) 13.552(3) 10.379(4) 8.0428(9)
b (A˚) 14.582(3) 11.285(4) 11.4031(14)
c (A˚) 17.920(6) 15.601(6) 11.7074(13)
a () 90 108.602(5) 93.585(14)
b () 126.31(2) 91.211(5) 96.862(14)
c () 90 104.887(5) 98.154(14)
V (A˚3) 2853.6(13) 1663.0(10) 1051.8(2)
Z 4 2 2
T (K) 173(2) 120(2) 173(2)
Dc (g cm
3) 1.673 1.571 2.062
l (mm1) 0.729 0.635 6.613
Scan range () 1.86 < h < 29.24 1.98 < h < 28.23 2.58 < h < 26.03
Unique reﬂections 6277 7437 3821
Reﬂections used [I > 2r(I)] 4388 6379 3518
Rint 0.0588 0.0261 0.0501
Final R indices [I > 2r(I)]a 0.0387, wR2 0.0860 0.0457, wR2 0.1073 0.0323, wR2 0.0782
R indices (all data) 0.0605, wR2 0.0926 0.0543, wR2 0.1131 0.0373, wR2 0.0884
Goodness-of-ﬁt 0.910 1.016 1.112
Maximum and minimum Dq (e A˚3) 0.763, 1.038 0.754, 0.530 1.775, 1.850
a Structures were reﬁned on Fo
2: wR2 = [
P
[w(Fo
2  Fc2)2]/
P
w(Fo
2)2]1/2, where w1 = [
P
(Fo
2) + (aP)2 + b] and P = [max(Fo
2, 0) + 2Fc
2]/3.
Fig. 1. ORTEP diagram with labelling scheme for [CpRu{2-(2 0-pyr-
idyl)imidazole}(PPh3)]
+ ([1]PF6), at 50% probability level, H-atoms and
PF6 anion omitted for clarity.
Fig. 2. ORTEP diagram with labelling scheme for [CpRu{2-(2 0-pyr-
idyl)benzimidazole}(PPh3)]
+ ([2]PF6 Æ H2O) at 50% probability level, H-
atoms, PF6 anion and water molecule omitted for clarity.
4to the precursor complexes (4.43–4.31 ppm). The downﬁeld
shift position of the cyclopentadienyl protons in complexes
1–6, which might results from the change in electron den-
sity on the metal center due to chelation of the nitrogen
base ligands through the nitrogen atoms of the 2-(2 0-pyr-
idyl)imidazole derivatives ligands. The 1H NMR spectra
of complexes 1–6 also showed two pseudo-triplets in the
range of 7.85–6.32 ppm due to the pyridine protons (H4and H5) of the N \ N-donor ligands, a singlet at
12.01 ppm corresponds to the NH protons of the ligands.
The spectra of the Cp* complexes 7 and 8 showed reso-
nance for the methyl protons of the Cp* ligand as singlets
at 1.86 ppm and 1.82 ppm, respectively.
Molecular structure of the representative hexaﬂuoro-
phosphates salts [1]PF6, [2]PF6 and [7]PF6 are presented
in Figs. 1, 2 and 4, respectively. Selected bond lengths
and angles are recorded in Table 2. The molecular
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Fig. 4. ORTEP diagram with labelling scheme for [Cp*Ir{2-(2
0-pyr-
idyl)imidazole}Cl]+ ([7]PF6) at 50% probability level, H-atoms and PF6
anion omitted for clarity.
Table 2
Selected bond lengths and angles for complexes [1]PF6, [2]PF6 Æ H2O and
[7]PF6
1 2 7
Distances (A˚)
Ru–P 2.316(1) 2.325(1)
Ir–Cl 2.4183(14)
M–N1 2.113(3) 2.1169(17) 2.106(5)
M–N3 2.093(3) 2.0939(15) 2.080(5)
M–C1 2.208(4) 2.109(4) 2.178(6)
M–C2 2.177(4) 2.157(3) 2.149(5)
M–C3 2.150(4) 2.226(3) 2.158(6)
M–C4 2.180(4) 2.219(3) 2.144(6)
M–C5 2.215(4) 2.146(4) 2.164(6)
Angles ()
N1–M–N3 75.98(10) 76.08(17) 76.48(19)
N1–M–P1 90.12(8) 92.15(6)
N3–M–P1 87.66(8) 89.02(6)
N1–Ir–Cl1 84.60(14)
N3–Ir–Cl1 86.95(14)
Fig. 3. Hydrogen-bonded system observed in [2]PF6 Æ H2O.
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5structures of [CpRu{2-(2 0-pyridyl)imidazole}(PPh3)]
+ (1
and [CpRu{2-(2 0-pyridyl)benzimidazole}(PPh3)]
+ (2) hav
been established by single-crystal X-ray structure analys
of [1]PF6 and [2]PF6  H2O, respectively. Both complexe
show typical piano-stool geometry with the metal cente
coordinated by a cyclopentadienyl ligand, a PPh3 ligan
and a chelating N \ N-ligand, see Figs. 1 and 2.
The Ru–N bond distances [2.113(3) and 2.093(3) A˚ i
1; 2.117(2) and 2.094(2) in 2] are comparable to thos
in [(g6-p-PriC6H4Me)RuCl(2,3-bis(2-pyridyl)pyrazine)
BF4[17] and [(g6-C6H6)RuCl(2-(1-imidazole-2-yl)pyr
dine)]PF6 [18a]. Accordingly, there is no signiﬁcan
diﬀerence in the Ru–P bond length in 1 [2.316(1) A˚] o2 [2.325(1) A˚] with reported values [9d,19]. The N(1)
Ru–N(3) bond angle in complexes 1 [76.0(1)] and
[76.1(2)] are similar to those of compounds [(g6-p-PriC6H
Me)RuCl(2,3-bis(2-pyridyl)pyrazine)]+ [N–Ru–N = 76.
(2)] [17] and [(g6-p-PriC6H4Me)RuCl(2,3-bis(a-pyr
idyl)quinoxaline)]+ [N–Ru–N = 76.2(2)] [18b]. The angle
between the least-square planes of g5-C5H5 and that o
the N \ N-ligand are 57.8(2) in 1 and 55.3(2) in 2.
Complex [2]PF6 crystallizes with one molecule of wate
per asymmetric unit, which forms a hydrogen-bonded ne
work with two hexaﬂuorophosphate anions and the N–H
group of the N \ N ligand, see Fig. 3. The N–O and O
F distances of the hydrogen bonds are, respectively
2.820(3) A˚ for the N–H of the 2-(2 0-pyridyl)benzimidazol
Fig. 5. Dimeric structure of [7]PF6 showing the intermolecular NH  Cl hydrogen contacts and p–p interacting system.
6ligand and H2O, and 2.941(4) and 2.907(4) A˚ between the
hexaﬂuorophosphate anions and the water molecule. The
N–H  O angle is 167.1 while the O–H  F angles are
178 and 153, respectively.
The molecular structure of [Cp*Ir{2-(2
0-pyridyl)imidaz-
ole}Cl]+ (7) has been established by single-crystal X-ray
structure analysis of [7]PF6 (see Fig. 4). The complex shows
a typical piano-stool geometry with the metal center
coordinated by the pentamethylcyclopentadienyl ligand, a
terminal chloride and the 2-(2 0-pyridyl)imidazole ligand.
The Ir–N bond distances [2.106(5) and 2.080(5) A˚] are
slightly shorter to those in [1]PF6 and [2]PF6. The average
distance between the metal atom and the carbon atoms of
the g5-C5Me5 ring is 2.16 A˚. This average bond length is
comparable to that in the related g5-C5Me5 iridium
complex [(g5-C5Me5)IrCl((S)-1-phenylethylsalicylaldii-
mine)] [2.17 A˚] [20]. The Ir–Cl bond length is 2.4183(14)
A˚ in 7, which is slightly longer to the reported iridium com-
plex [(g5-C5Me5)IrCl((S)-1-phenylethylsalicylaldiimine)]
[2.4017(16) A˚] [20].
In the crystal packing of [7]PF6, two molecules of 7 form
a dimer through N–H  Cl contacts and p-stacking interac-
tions, see Fig. 5. The N–Cl separation is 3.254(5) A˚ with an
N–H  Cl angle of 162.1. The distance observed between
the p-stacking interacting systems (centroid  centroid
3.76 A˚) is in good agreement with the theoretical value
calculated for this stacking mode [21]. The distance
observed between the two iridium centers of the dimer
is 7.841(1) A˚ and excludes any possible metal–metal
interactions.4. Conclusions
The present study describes the synthesis of eight
new CpRu, CpOs and Cp*Ir complexes containing 2-
(2 0-pyridyl)imidazole ligands. Representative complexes
have been characterized by single X-ray study. In the
crystal packing of [7]PF6, two molecules of 7 form a
dimer through N–H  Cl contacts and p-stacking
interactions.Acknowledgements
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Appendix A. Supplementary material
CCDC 637370, 637371 and 637372 contain the supple-
mentary crystallographic data for [1]PF6, [2]PF6 Æ H2O
and [7]PF6. These data can be obtained free of charge via
http://www.ccdc.cam.ac.uk/conts/retrieving.html, or from
the Cambridge Crystallographic Data Centre, 12 Union
Road, Cambridge CB2 1EZ, UK; fax: (+44) 1223-336-
033; or e-mail: deposit@ccdc.cam.ac.uk. Supplementary
data associated with this article can be found, in the online
version, at doi:10.1016/j.poly.2007.03.055.
References
[1] (a) W. Baratta, E. Herdtweck, W.A. Hermann, P. Rigo, J. Schwarz,
Organometallics 21 (2002) 2101;
(b) M.A. Bennett, K. Khan, E. Wenger, in: G. Wilkinson, F.G.A.
Stone, E.W. Abel (Eds.), Comprehensive Organometallic Chemistry
II, second ed., vol. 7, Elsevier, Oxford, 1995, Chapter 8 and references
cited therein.
[2] (a) S.G. Davies, J.P. McNally, J. Smallridge, Adv. Organomet. Chem.
30 (1991) 1;
(b) B.M. Trost, J.A. Marting, R.J. Kulawiec, A.F. Indolese, J. Am.
Chem. Soc. 115 (1993) 10402;
(c) P. Pertici, V. Ballantini, P. Salvadori, M.A. Bennett, Organomet-
allics 14 (1995) 2565;
(d) D.L. Davies, J. Fawcett, R. Krafczyk, D.R. Russell, J. Organo-
met. Chem. 545–546 (1997) 581.
[3] (a) B.M. Trost, M.U. Frederiksen, M.T. Rudd, Angew. Chem., Int.
Ed. Eng. 44 (2005) 6630, and references cited therein;
(b) W. Baratta, A.D. Zotto, P. Rigo, Chem. Commun. (1997) 2163;
(c) A.D. Zotto, W. Baratta, G. Verardo, P. Rigo, Eur. J. Org. Chem.
(2000) 2795.
[4] M.A. Esteruelas, E.G. Puebla, A.M. Lo´pez, E. On´ate, J.I. Tolosa,
Organometallics 19 (2000) 275.
nJ.
6)
e-
g,
1)
J.
n,
.
.,
n
4
J.
h,
1
r-
c
.
.
6)
.
n
.
7[5] (a) R. Lalrempuia, H. Yennawar, Y.A. Mozharivskyj, K. Moha
Rao, J. Organomet. Chem. 689 (2004) 539;
(b) T. Wilczewski, J. Organomet. Chem. 317 (1986) 307;
(c) T. Wilczewski, J. Organomet. Chem. 297 (1985) 331;
(d) M.I. Bruce, G.A. Koutsantonis, M.J. Liddel, B.K. Nicholson,
Organomet. Chem. 320 (1987) 217, and references cited therein.
[6] (a) P. Govindaswamy, K. Mohan Rao, J. Coord. Chem. 59 (200
663;
(b) P. Govindaswamy, Y.A. Mozharivskyj, K. Mohan Rao, Polyh
dron 24 (2005) 1710;
(c) H. Aneetha, P.S. Zacharias, B. Srinivas, G.H. Lee, Y. Wan
Polyhedron 18 (1999) 299.
[7] (a) T. Blackmore, M.I. Bruce, F.G.A. Stone, J. Chem. Soc. A (197
2376;
(b) G.S. Ashby, M.I. Bruce, I.B. Tomkins, R.C. Wallis, Aust.
Chem. 32 (1979) 1003;
(c) S.G. Davies, S.J. Simpson, H. Felkin, T. Fillebeen-Kha
Organometallics 2 (1983) 539;
(d) S.G. Davies, S.J. Simpson, H. Felkin, T. Fillebeen-Khan, F
Tadjand, O. Watts, J. Chem. Soc., Chem. Commun. (1981) 341;
(e) M.I. Bruce, S.F. Wong, B.W. Skelton, A.H. White, J. Chem. Soc
Dalton Trans. (1981) 1398.
[8] (a) J.P. Selegue, Organometallics 1 (1982) 217;
(b) J.P. Selegue, J. Am. Chem. Soc. 105 (1983) 5921.
[9] (a) R. Lalrempuia, P. Govindaswamy, Y.A. Mozharivskyj, K. Moha
Rao, Polyhedron 23 (2004) 1069;
(b) K. Mohan Rao, E.K. Rymmai, Polyhedron 22 (2003) 307;(c) K. Sarjit Singh, P.J. Carroll, K. Mohan Rao, Polyhedron 2
(2005) 391;
(d) K. Sarjit Singh, Y.A. Mozharivskyj, C. Thone, K. Mohan Rao,
Organomet. Chem. 690 (2005) 3720.
[10] B. Chiswell, F. Lions, B.S. Morris, Inorg. Chem. 31 (1964) 110.
[11] (a) M.I. Bruce, N.J. Windsor, Aust. J. Chem. 30 (1977) 1601;
(b) M.I. Bruce, P.J. Low, B.W. Skelton, E.R.T. Tiekink, A. Wert
A.H. White, Aust. J. Chem. 48 (1995) 1887.
[12] (a) J.W. Kang, K. Moseley, P.M. Maitlis, J. Am. Chem. Soc. 9
(1969) 5970;
(b) C. White, A. Yates, P.M. Maitlis, Inorg. Synth. 29 (1992) 228.
[13] M. Sheldrick, Acta Crystallogr., Sect. A 46 (1990) 467.
[14] M. Sheldrick, SHELXL-97, University of Go¨ttingen, Go¨ttingen, Ge
many, 1999.
[15] L.J. Farrugia, J. Appl. Cryst. 30 (1997) 565.
[16] I.J. Bruno, J.C. Cole, P.R. Edgington, M. Kessler, C.F.Macrae, P. M
Cabe, J. Pearson, R. Taylor, Acta Crystallogr., Sect. B 58 (2002) 389
[17] A. Singh, N. Singh, D.S. Pandey, J. Organomet. Chem. 642 (2002) 48
[18] (a) H. Mishra, R. Mukherjee, J. Organomet. Chem 691 (200
3545;
(b) R. Lalrempuia, K. Mohan Rao, Polyhedron 22 (2003) 3155.
[19] P. Govindaswamy, C. Sinha, K. Mohan Rao, J. Organomet. Chem
690 (2005) 3465.
[20] H. Brunner, A. Ko¨llnberger, T. Burgemeister, M. Zabel, Polyhedro
19 (2000) 1519.
[21] S. Tsuzuki, K. Honda, T. Uchimura, M. Mikami, K. Tanabe, J. Am
Chem. Soc. 124 (2002) 104.
